Clinical Trial Update: Fremanezumab, Migraine and Sleep [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Fremanezumab in migraine disorders and sleep disorders; the study was terminated with results posted on 2026-02-27.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Sleep Disorders

Drugs mentioned

• Ajovy (fremanezumab)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Migraine Disorders, Sleep Disorder | Phase 4 | Status: TERMINATED | Results posted: 2026-02-27